Abbott Laboratories Return on Investment 2010-2024 | ABT
Current and historical return on investment (ROI) values for Abbott Laboratories (ABT) over the last 10 years.
| Abbott Laboratories ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-03-31 | $6.36B | $51.62B | 12.21% |
| 2023-12-31 | $6.48B | $52.43B | 12.43% |
| 2023-09-30 | $6.00B | $52.17B | 11.58% |
| 2023-06-30 | $6.13B | $51.97B | 11.87% |
| 2023-03-31 | $6.96B | $51.85B | 13.39% |
| 2022-12-31 | $8.36B | $51.43B | 16.02% |
| 2022-09-30 | $9.44B | $51.18B | 17.91% |
| 2022-06-30 | $10.21B | $53.47B | 19.31% |
| 2022-03-31 | $9.23B | $52.72B | 17.60% |
| 2021-12-31 | $8.43B | $53.32B | 16.18% |
| 2021-09-30 | $8.48B | $52.08B | 16.43% |
| 2021-06-30 | $7.43B | $51.58B | 14.54% |
| 2021-03-31 | $6.71B | $51.28B | 13.30% |
| 2020-12-31 | $5.36B | $51.53B | 10.84% |
| 2020-09-30 | $4.31B | $49.94B | 8.89% |
| 2020-06-30 | $4.02B | $48.98B | 8.29% |
| 2020-03-31 | $4.55B | $47.23B | 9.30% |
| 2019-12-31 | $4.53B | $47.96B | 9.13% |
| 2019-09-30 | $4.31B | $49.66B | 8.59% |
| 2019-06-30 | $4.11B | $50.88B | 8.16% |
| 2019-03-31 | $3.78B | $49.97B | 7.53% |
| 2018-12-31 | $3.65B | $50.08B | 7.17% |
| 2018-09-30 | $3.14B | $50.18B | 5.92% |
| 2018-06-30 | $2.91B | $50.60B | 5.36% |
| 2018-03-31 | $2.41B | $52.76B | 4.35% |
| 2017-12-31 | $1.56B | $58.31B | 2.78% |
| 2017-09-30 | $1.70B | $55.53B | 3.28% |
| 2017-06-30 | $1.83B | $55.60B | 4.09% |
| 2017-03-31 | $2.26B | $55.31B | 6.01% |
| 2016-12-31 | $3.03B | $41.40B | 9.93% |
| 2016-09-30 | $3.05B | $26.87B | 11.34% |
| 2016-06-30 | $2.87B | $26.81B | 10.62% |
| 2016-03-31 | $2.78B | $26.82B | 10.10% |
| 2015-12-31 | $2.87B | $27.20B | 10.31% |
| 2015-09-30 | $2.88B | $27.17B | 10.56% |
| 2015-06-30 | $2.90B | $28.99B | 10.66% |
| 2015-03-31 | $2.84B | $27.92B | 10.65% |
| 2014-12-31 | $2.60B | $25.03B | 9.83% |
| 2014-09-30 | $2.19B | $26.71B | 8.00% |
| 2014-06-30 | $1.93B | $27.11B | 7.04% |
| 2014-03-31 | $1.88B | $26.88B | 6.94% |
| 2013-12-31 | $2.13B | $28.66B | 7.91% |
| 2013-09-30 | $1.69B | $27.19B | 5.45% |
| 2013-06-30 | $1.53B | $25.84B | 4.50% |
| 2013-03-31 | $1.47B | $26.15B | 3.99% |
| 2012-12-31 | $1.36B | $44.90B | 3.44% |
| 2012-09-30 | $3.47B | $39.16B | 9.26% |
| 2012-06-30 | $3.75B | $36.58B | 10.11% |
| 2012-03-31 | $4.96B | $37.41B | 13.15% |
| 2011-12-31 | $5.75B | $36.57B | 15.26% |
| 2011-09-30 | $5.50B | $37.79B | 14.72% |
| 2011-06-30 | $6.09B | $39.10B | 16.67% |
| 2011-03-31 | $5.92B | $37.25B | 16.96% |
| 2010-12-31 | $6.09B | $35.29B | 18.15% |
| 2010-09-30 | $6.12B | $34.39B | 18.36% |
| 2010-06-30 | $6.58B | $32.61B | 19.95% |
| 2010-03-31 | $6.65B | $31.89B | 20.35% |
| 2009-12-31 | $6.24B | $34.45B | 19.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $182.053B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $129.729B | 31.07 |
| Boston Scientific (BSX) | United States | $112.966B | 35.98 |
| Medtronic (MDT) | Ireland | $101.722B | 15.23 |
| EssilorLuxottica (ESLOY) | France | $99.494B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.384B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.493B | 28.10 |
| ResMed (RMD) | United States | $28.144B | 26.42 |
| Terumo (TRUMY) | Japan | $24.477B | 34.57 |
| Koninklijke Philips (PHG) | Netherlands | $23.276B | 18.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.297B | 14.24 |
| Baxter (BAX) | United States | $17.081B | 12.15 |
| Insulet (PODD) | United States | $14.497B | 64.28 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.820B | 0.00 |
| Demant (WILYY) | Denmark | $9.620B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.758B | 25.37 |
| BellRing Brands (BRBR) | United States | $7.565B | 35.58 |
| Lantheus Holdings (LNTH) | United States | $5.636B | 14.04 |
| Haemonetics (HAE) | United States | $4.238B | 20.90 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.475B | 16.54 |
| Perrigo (PRGO) | Ireland | $3.467B | 10.51 |
| Neogen (NEOG) | United States | $3.457B | 33.25 |
| ICU Medical (ICUI) | United States | $2.893B | 25.53 |
| Envista Holdings (NVST) | United States | $2.832B | 11.69 |
| TG Therapeutics (TGTX) | United States | $2.774B | 78.04 |
| Green Thumb Industries (GTBIF) | United States | $2.724B | 53.33 |
| Agios Pharmaceuticals (AGIO) | United States | $2.476B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.246B | 12.47 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.784B | 0.00 |
| Warby Parker (WRBY) | United States | $1.611B | 0.00 |
| InMode (INMD) | Israel | $1.517B | 8.06 |
| Verano Holdings (VRNOF) | United States | $1.455B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.313B | 9.76 |
| AtriCure (ATRC) | United States | $1.108B | 0.00 |
| Owens & Minor (OMI) | United States | $1.051B | 9.16 |
| National Vision Holdings (EYE) | United States | $0.995B | 31.67 |
| BioLife Solutions (BLFS) | United States | $0.944B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.871B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.697B | 14.83 |
| Evolus (EOLS) | United States | $0.684B | 0.00 |
| PetIQ (PETQ) | United States | $0.659B | 21.31 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.598B | 14.06 |
| Canopy Growth (CGC) | Canada | $0.508B | 0.00 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| ZimVie (ZIMV) | United States | $0.480B | 40.91 |
| Biote (BTMD) | United States | $0.458B | 10.56 |
| TerrAscend (TSNDF) | Canada | $0.426B | 0.00 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Zynex (ZYXI) | United States | $0.287B | 39.26 |
| Ayr Wellness (AYRWF) | United States | $0.266B | 0.00 |
| MacroGenics (MGNX) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.251B | 24.89 |
| Sanara MedTech (SMTI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.86 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.156B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.152B | 21.57 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 10.11 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Bright Green (BGXX) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
| Allurion Technologies (ALUR) | United States | $0.062B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.47 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |